[2 min watch] Charging for procedures in a bulk-billing practice

procedures

If you are in a practice that bulk-bills skin cancer procedures, can you charge any other fees in relation to that procedure, such as a procedure fee or a consumables fee? In this short video, Matt Woollard (Chief Operating Officer, National Skin Cancer Centres) talks about the regulations relating to Medicare and billing skin cancer procedures. Continue reading “[2 min watch] Charging for procedures in a bulk-billing practice”

[3 min watch] Top 3 suturing tips

suturing

In this short video, Skin Cancer Doctor Hamilton Ayres shares his top three suturing tips, ideal for doctors who manage skin cancer surgery patients in primary care. Continue reading “[3 min watch] Top 3 suturing tips”

[2 min watch] When should you refer skin cancer surgery patients to specialists?

skin cancer surgery

Even the most experienced skin cancer doctors can sometimes face challenging surgical cases that simply can’t be appropriately managed in the primary care or skin cancer clinic setting. In this short video, Dr Tony Azzi talks about some of the circumstances in which he might refer a skin cancer surgery patient to a specialist.
Continue reading “[2 min watch] When should you refer skin cancer surgery patients to specialists?”

[2 min read] Surgery vs curettage & imiquimod for nodular BCC

nodular BCC

Nodular basal cell carcinoma (BCC) is most often treated with surgical excision. However, interest is increasing in minimally invasive treatments for these low-risk skin cancers. A new study reviewed the effectiveness of surgical excision compared with curettage and imiquimod cream in treating nodular BCC. Continue reading “[2 min read] Surgery vs curettage & imiquimod for nodular BCC”

[4 min watch] 4 common mistakes to avoid in skin cancer surgery

mistakes

If you are a primary care physician performing skin cancer surgery in your practice, there are a few common pitfalls you may encounter. In this short video, experienced skin cancer surgeon Dr Tony Azzi shares the four most common mistakes he sees in this field of medicine, and offers his top tips for avoiding them. Continue reading “[4 min watch] 4 common mistakes to avoid in skin cancer surgery”

[1 min watch] How to get referrals and recommend skin checks to patients

In order to get referrals for skin cancer checks from your colleagues, it’s essential to gain their confidence that you can manage the work. In this short video, Matt Woollard (Chief Operating Officer, National Skin Cancer Centres) provides an insight into how to get referrals and recommend skin checks to patients.

Continue reading “[1 min watch] How to get referrals and recommend skin checks to patients”

[2 min watch] Tips to manage common skin cancer surgery complications

Posted on
surgery complications

In this short video, Dr Tony Dicker offers his top tips for managing common skin cancer surgery complications you might encounter as a GP, primary care or skin cancer doctor. Continue reading “[2 min watch] Tips to manage common skin cancer surgery complications”

[5 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [March 2020]

skin cancer update

In this month’s skin cancer update video, Professor Giuseppe Argenziano talks about the criteria for sentinel node biopsies in melanoma patients. Using real patient case examples, he gives practical advice for how best to assess these patients to optimise their outcomes while avoiding unnecessary procedures. Continue reading “[5 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [March 2020]”

[WEBINAR] Hints for skin cancer surgery below the knee

skin cancer surgery

In this webinar, Dr Tony Dicker discussed performing skin cancer surgery in the difficult area below the knee with practical hints and tips for best results. Continue reading “[WEBINAR] Hints for skin cancer surgery below the knee”

[5 min read] First-line treatment decisions for BRAF-mutated melanoma

melanoma treatment
How do you determine first-line treatment for your patients with melanoma? Treatment decisions for advanced melanoma are increasingly complex and guidelines provide limited advice on how to choose between immunotherapy and targeted therapy for first-line treatment. A Delphi study was carried out to understand which patient characteristics and disease-related factors inform clinicians’ choices of first-line treatment for BRAF-mutated melanoma.

Continue reading “[5 min read] First-line treatment decisions for BRAF-mutated melanoma”